The largest database of trusted experimental protocols

10 protocols using plxsn

1

Stable Expression of linc-AAM in Mammalian Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cDNA of linc-AAM was amplified using high fidelity polymerase PrimeSTAR Max (TaKaRa) and was subcloned into the retroviral vector pLXSN (Clontech) for stable expression in mammalian cells and subcloned into the pcDNA3.1(-) eukaryotic expression vector (Invitrogen) for performing in vitro transcription reactions and translation activity assay. All constructs were confirmed by DNA sequencing. The reconstituted linc-AAM-pLXSN vector, mutant linc-AAM-pLXSN vectors and control pLXSN vector were transfected to PT67 cells (Clontech), respectively. After 24 h, cells were selected for stable integrants with G418 (500 mg/mL). The stable cell lines were reseeded in 100-mm dishes and the supernatants containing virus particles were collected after 5 days cultivation, pooled together, and filtered through a 0.45-mM nitrocellulose filter (Millipore). RAW264.7 cells were transduced in the presence of polybrene (8 mg/mL; Thermo Fisher Scientific), and selected for stable integrants with G418 (1 mg/mL) as bulk cultures. All stable cell lines were used for experiments at early passages.
+ Open protocol
+ Expand
2

Overexpression of GATA3 and PPARG1

Check if the same lab product or an alternative is used in the 5 most similar protocols
GATA3 and PPARG overexpression was achieved by cloning consensus coding sequences for full-length GATA3 protein (CCDS31143) and the PPARγ1 protein variant (termed "PPARG1" throughout; CCDS2610) into the retroviral vector pLXSN (Clontech) and verified by Sanger sequencing. The pLXSN-GATA3 and pLXSN-PPARG1 plasmids were transfected into PT67 retrovirus packaging cells (Clontech) and selected using G418. NHB cells were transduced with conditioned medium from PT67 cells containing replication-defective retrovirus and selected using G418. Control NHB cells were transduced with the pLXSN vector only (Empty).
+ Open protocol
+ Expand
3

Plasmid Constructs for Viral Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
SV-Psi-Env-MLV [8 (link)], pHIV-1 LAI gp160 [9 (link)], pHCMV-VSV-G [4 (link)] and pSIVmac gp130 [10 (link)] were previously described. L-LUC-SN was constructed by inserting the firefly luciferase gene within the polylinker of pLXSN (Clonetech, cat# 631509). pSARS-CoV-1 was purchased from Sino Biologicals. pCAGGS expressing SARS-CoV-2 RBD was obtained from BEI Resources (cat#NR-52309). The plasmid pcDNA3.1-SARS-2-S-C9 was a generous gift from Tom Gallagher and expresses a codon-optimized SARS-CoV-2 spike open reading frame with a deletion in the 19 carboxy-terminal amino acids (an endoplasmic reticulum retention signal) and addition of the C9 peptide TETSQVAPA, recognized by antibody 1D4.
+ Open protocol
+ Expand
4

Optimized SARS-CoV-2 Spike Expression System

Check if the same lab product or an alternative is used in the 5 most similar protocols
SV-Psi-Env-MLV [8 (link)], pHIV-1 LAI gp160 [9 (link)], pHCMV-VSV-G [4 (link)] and pSIVmac gp130 [10 (link)] were previously described. L-LUC-SN was constructed by inserting the firefly luciferase gene within the polylinker of pLXSN (Clonetech, cat# 631509). pSARS-CoV-1 was purchased from Sino Biologicals. pCAGGS expressing SARS-CoV-2 RBD was obtained from BEI Resources (cat#NR-52309). HEK293T-hACE2 cells were a gift from Adam Bailey and Emma Winkler and were constructed as follows. A DNA fragment containing a codon-optimized version of hACE2 (Genbank NM_021804) was inserted into pLV-EF1a-IRES-Hygro (Addgene Plasmid #85134) using Gibson assembly. 293T cells were then transduced with lentivirus made from this construct. The plasmid pcDNA3.1-SARS-2-S-C9 was a generous gift from Tom Gallagher and expresses a codon-optimized SARS-CoV-2 spike open reading frame with a deletion in the 19 carboxy-terminal deletion amino acids (an endoplasmic reticulum retention signal) and addition of the C9 peptide TETSQVAPA, recognized by antibody 1D4.
+ Open protocol
+ Expand
5

Generating Constitutively Fluorescent Glioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate constitutively fluorescent glioma cells, GFP was cloned into mammalian retroviral expression vector pLXSN (Clonetech, Mountain View, California, USA). Virus was generated using GFP cDNA cloned in pLXSN and packaged using Phoenix A cells. U251 human glioma cells (American Type Culture Collection, Manassas, Virginia, USA) were infected with the virus and selected for GFP expression by fluorescence-activated cell sorting.
+ Open protocol
+ Expand
6

Generating TRIM5 Variants with Retroviral Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length cDNA from human TRIM5alpha was obtained from RT-PCR amplification of HeLa cells RNA. The TRIM5alpha P479L was obtained by recombinant PCR by exchanging the human TRIM5alpha exon 8 with the corresponding mutated allele from patient #H1. The full-length owl-TRIMcypA cDNA was PCR amplified from plasmid pMIG-TRIMCyp obtained from the NIH AIDS reagents program65 (link). Mafa-TRIMCypA and mamu-TRIMCypA were kind gifts of Dr. Greg Towers68 (link)86 (link). The TRIM-CypNup358 was obtained by recombinant PCR as previously described57 (link). All PCR products were cloned into a retroviral vector containing two C-terminus hemagglutinin (HA) tags derived from pLXSN (Clontech). HEK-293T cells were then independently co-transfected with the pLXSN-based retroviral vectors encoding the various HA-tagged TRIM5 variants along with plasmids expressing MLV Gag-Pol and the vesicular stomatitis virus (VSV) G envelope glycoprotein (pCSIG)87 (link). Forty-eight hours after transfection, the retroviral supernatants were harvested and used to transduce dunni cells grown in the presence of G418 at 2 mg/ml (Invivogen) to select stable expression of TRIM5.
+ Open protocol
+ Expand
7

Transcription Factor Expression Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 6OSE2-luc reporter, pCMV wild-type Runx2 (RUNX2-WT), S301,319A Runx2 (RUNX2-SA) and S301,319E Runx2 (RUNX2-SE expression vectors were previously described (Ge et al., 2009 (link)) as were ARE-luc, RXR, wild-type PPARɣ (PPARɣ-WT), S112A PPARɣ (PPARɣ-SA), S112E PPARɣ (PPARɣ-SE) (Perez et al., 1993 (link); Camp and Tafuri, 1997 (link)), constitutively active MEK1 (Meksp) and dominant negative MEK1 (Mekdn) expression vectors (Zheng and Guan, 1993 (link)). Adenovirus expressing Meksp and Mekdn were generated by subcloning the cDNA of Meksp and Mekdn into Adloxp shuttle vector and generating adenovirus using Cre-Lox recombination (Hardy et al., 1997 (link)). Retrovirus expression vectors for wild type and mutant RUNX2 and PPARɣ were developed by subcloning appropriate cDNAs into the retrovirus vector, pLXSN (Clontech, Mountain View, CA). Adenovirus and retrovirus were produced in the University of Michigan Vector.
+ Open protocol
+ Expand
8

Generating FL-RAGE Expression Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to construct pcDNA-neo-FL-RAGE or p-LXSN-neo-FL-RAGE vectors, the human FL-RAGE cDNA (GenBank2 accession no. NM001136) was excised from a pre-existing vector by using EcoRI and XhoI restriction endonucleases (New England Biolabs, MA, USA) and inserted into pcDNA-3 or pLXSN (Clontech, CA, USA) digested with same enzymes. To generate pCAGS-IRES-GFP-FL-RAGE, human FL-RAGE cDNA was excised with XhoI, filled-in to create blunt ends, and subsequentially digested with EcoRI. The purified cDNA was then inserted in pCAGS-IRES-GFP (kindly provided by Vania Broccoli) cut with EcoRI and SmaI (Promega, USA).
+ Open protocol
+ Expand
9

Viral and cellular gene expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cellular and viral genes were expressed using the retroviral vector pLXSN (Clontech, Palo Alto, CA) or the expression vector pcDNA-3 (Invitrogen). The pLXSN-LMP-1 and the mutants LMP-1AxAxA, LMP-1 378 stop, and LMP-1AxAxA/378 stop constructs have been previously described [41] . The pGL3 basic luciferase reporter (Promega) and pGL3 containing the DOK1 promoter constructs have been described previously [29] (link), The NF-κB super-repressor Δ-IκBα, which lacks the coding sequence of the first 36 N-terminal amino-acids, was kindly provided by Dr Elliot Kieff (Harvard Medical School, Boston, Massachusetts, USA). The expression plasmids pDEST-myc-EBNA1, pSG5-EBNA2, pDEST-myc-EBN3A1, pDEST-myc-EBNA3B, pDEST-myc-EBNA3C were kindly provided by Dr Evelyne Manet (ENS, Lyon, France).
+ Open protocol
+ Expand
10

Establishment of GFP-expressing Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cultures were maintained at 37oC in 10% CO2 in Dulbecco's Modified Eagles Medium supplemented with nonessential amino acids, pyruvate, L-glutamine, gentamicin, and 10% FBS. DLD-1 human colon cancer cells were obtained from the Americian Type Culture Collection. OE33 human esophageal cancer cells originated from the European Collections of Cell cultures and were provided to us by Dr. Rebecca Fitzgerald, Cambridge University, UK. To obtain OE33-GFP and OE33-IRES-GFP, we stably modified OE33 cells with plasmid constructs pLXSN-GFP (for OE33-GFP) and pLXSN-IRES-GFP (for OE33-IRES-GFP), in which GFP message is translated in a cap-dependent or cap-independent manner, respectively. The GFP and IRES (ECMV) sequences were derived from pIRES-GFP (Clontech, Mountainview, CA). pLXSN was obtained from Clontech, Mounainview, CA. GFP-expressing clones were selected in G418 followed by cell sorting. Mouse Embryo Fibroblasts, nullizygous for p53 and mdm2, were generously provided by Dr. Guillermina Lozano, Department of Molecular Genetics, the University of Texas M.D. Anderson Cancer Center, Houston, TX.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!